AbstractBackgroundUnderstanding phenotypic variations in left ventricular (LV) dysfunction during cancer therapy may allow for tailored surveillance and prevention.ObjectivesThis study sought to de…
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
A selection committee of approximately 120 eminent oncologists has chosen honorees who have achieved landmark successes within the global field of oncology to propel the…
In this eye-opening episode, host Joe Fier sits down with renowned integrative cardiologist Dr. Joel Kahn to discuss the hidden drivers behind heart disease,…
Get tickets online for Oncology Brothers Live Event (ASCO Annual Meeting) here.
Highlights •Cardiac amyloidosis is an infiltrative cardiomyopathy that results in wall thickening and diastolic dysfunction.•Contractile assays, histology, and biochemical assays were performed on …
AbstractBackgroundInclisiran administration twice-yearly (after initial and 3-month doses) effectively reduces low-density lipoprotein cholesterol (LDL-C) in patients on maximally tolerated statins…
AbstractBackgroundhERG encodes KV11.1 voltage-gated K+ channels, which generate the rapidly activating delayed rectifier K+ current that contributes to repolarization of the cardiac action potentia…
Blood Cancer Journal – The ratio of brain to liver glucose activity and disease activity in multiple myeloma
University of Missouri–Kansas City’s Healthcare Institute for Innovations in Quality, Kansas City, Missouri, USA Saint Luke’s Mid America Heart Institute, Kansas City, Missouri, USA Keio…
The FDA has granted Priority Review to pegcetacoplan (Empaveli) to treat C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).
